This study consists of 959 consecutive patients in whom endoscopic biopsies were taken according to a protocol that permitted mapping and measurement of epithelial types in the gastroesophageal region. The epithelial types were classified as normal (oxyntic and squamous) and questionably abnormal (oxyntocardiac, cardiac, intestinal) by strict histologic criteria. Patients were classified into four groups based on the length of histologically defined abnormal glandular epithelium in the measured biopsies. A total of 811 (84.6%) patients had 0 to 0.9 cm of questionably abnormal columnar epithelium between normal oxyntic mucosa and squamous epithelium. Of these, 161 (19.9%) patients had no abnormal epithelium, 158 (19.4%) patients had oxyntocardiac mucosa, 372 (45.9%) patients had cardiac mucosa, and 120 (14.8%) patients had intestinal metaplasia. A total of 148 (15.4%) patients had Ն1 cm of abnormal columnar epithelium. All but one patient in this group had cardiac or intestinal epithelia. The prevalence of intestinal epithelium increased progressively with increasing length of abnormal columnar epithelium, being present in 70.4% in the 1-to 2-cm group, 89.5% in the 3-to 4-cm group, and 100% with in the Ն5 cm group. We propose a histologic grading system of biopsies based on these findings.
The evaluation of biopsies in the gastroesophageal junctional region is complicated by controversy regarding anatomic terminology and the definition of what is normal and abnormal in this region. The term "cardia" is especially confusing because it is used anatomically to describe both the most proximal part of the stomach distal to the gastroesophageal junction and as an alternate term for the lower esophageal sphincter, as in "achalasia of the cardia." The term "cardia" is a purely anatomic term. "Cardiac mucosa" (CM) is a histologically defined term used for a mucosa in the gastrointestinal junctional region that contains only mucous cells, being devoid of parietal cells and goblet cells. 2, 3 Cardiac mucosa has been given alternative names such as "junctional" mucosa by Hayward in 1961 14 and Paull et al. in 1976 19 and "mucous-only" mucosa more recently by Glickman et al. 12 Whatever term is used, CM is accurately and highly reproducibly defined by histology.
The extent of CM that is normally present at the gastroesophageal junction has undergone considerable recent revision. Hayward, in 1961 , stated that CM (junctional mucosa) lined the distal 2 cm of the tubal esophagus and extended into the proximal stomach to a variable extent. 14 This was the basis of many historical definitions of Barrett esophagus. In 2000, Chandrasoma et al., in a study of normal autopsies, showed that CM was absent in 63 of 90 (70%) patients. 2 Jain et al., in a study of endoscopically normal patients without symptoms of reflux who had extensive biopsy sampling of the gastroesophageal junction, found CM to be absent in 65% of patients. 15 Glickman et al., in an endoscopic study of symptomatic pediatric patients, found CM to be absent in 19%. 12 The only contrary study is that of Kilgore et al., who found CM in all their normal pediatric autopsy patients; the length of CM had a range of 0.1 to 0.4 cm with a mean of 0.18 cm. 16 The study of Kilgore et al. 16 has fundamental defects 5 : 1) Measurements of CM were made from the squamocolumnar junction and represent stomach only if the authors' presumption that the squamocolumnar junction is identical to the gastroesophageal junction is correct. This presumes that gross examination of an autopsy specimen can recognize a 1-mm proximal migration of the squamous epithelium. 2) Cardiac mucosa was defined as a mucosa containing mucous cells and did not exclude mucosae with a mixture of parietal cells and mucous cells. The authors' illustration of CM actually shows a mucosa containing parietal cells imme-diately distal to the squamous epithelium, belying their contention that all patients had CM.
These studies indicate that CM, contrary to previously accepted dogma, is either absent in the gastroesophageal region or present in millimetric proportions in patients without symptoms of reflux. If the normal extent of CM is either zero or a few millimeters, CM certainly cannot line the anatomic cardia unless this is defined as an anatomic structure that may be absent in some people and found in millimetric terms in others. Studies that define "carditis" and "intestinal metaplasia of the gastric cardia" as the presence of inflammation and intestinal metaplasia in a mucosal biopsy from the anatomically defined gastric cardia produce confusing results. 1, 6, 10, 13 The mucosal lining of the anatomic gastric cardia and the region on both sides of the endoscopically defined gastroesophageal junction vary greatly in terms of histologic type over a very short distance. 17 Studies that define cardia by a biopsy taken 0.5 to 3 cm distal to the endoscopically defined gastroesophageal junction 1, 10, 13 are therefore as likely to contain gastric oxyntic mucosa as CM and inflammation as likely to represent gastritis as carditis. Those studies will produce different results to others in which carditis is defined by a biopsy immediately distal to the squamocolumnar junction 6 and studies in which carditis is defined purely in histologic terms. 7, 9 We have suggested that establishing histologic criteria for the assessment of biopsies from this region are more accurate and reproducible than using endoscopic definitions as presently recommended. 3 This study was undertaken to establish the prevalence of columnar epithelial types in the region of the gastroesophageal junction in a large population of patients with and without endoscopic abnormality.
MATERIALS AND METHODS
We studied 959 patients who underwent endoscopy and biopsy at the University of Southern California Foregut Surgery Unit in 1998 to 2000. Most of the patients in this study had symptoms that represented a clinical indication for upper endoscopy. Many patients were referred for consideration of anti-reflux surgery after medical management of reflux disease had failed. Patients were admitted into this study without consideration of symptoms or endoscopic abnormalities. The only two groups of patients who were excluded were patients with malignant neoplasms in this region and patients who had a history of surgery in this region.
Endoscopy was performed by the faculty of the University of Southern California Foregut Surgery Department using Olympus video-endoscopes, and biopsies were obtained with standard biopsy forceps (microvasive radial jaw 31263-20 or 1597-20). All patients underwent biopsy according to a standardized protocol.
Retroflex or antegrade biopsies were taken from the proximal limit of the rugal folds. In normal patients, the only other biopsy was an antegrade biopsy at the squamocolumnar junction, which was very close to the tops of the rugal folds. Patients with abnormal columnar epithelium between the tops of the rugal folds and the squamous epithelium had a retroflex biopsy at the tops of the rugal folds and antegrade biopsies between this and the squamocolumnar junction at 1-to 2-cm levels from the point of the retrograde biopsy at the tops of the rugal folds to the squamous epithelium. Biopsies were labeled solely by their distance from the incisor teeth except for the retroflex biopsy. Most patients also had biopsies of the distal stomach (antrum or body or both) and more proximal esophagus. There were two to five biopsies at each level.
Biopsies from all levels were processed separately, producing level-specific hematoxylin and eosin-stained sections. Giemsa stain was used to detect Helicobacter pylori. These sections were evaluated, and the types of lining epithelium seen at each level were recorded. The histologic types of epithelium were classified according to previously defined criteria, 2,3 as follows: 1) oxyntic mucosa, mucosa with straight tubular glands under the foveolar region composed of parietal and chief cells and devoid of mucus-secreting cells (Fig. 1) ; 2) CM, mucosa containing mucus-secreting epithelial cells and devoid of parietal cells (Fig. 2) ; 3) oxyntocardiac mucosa (OCM), mucosa with glands under the foveolar region composed of a mixture of mucus-secreting and parietal cells; the glands frequently had a lobular configuration (Fig. 3) ; 4) intestinal metaplastic epithelium (IM) defined by the presence of well-defined goblet cells in any number ( mucus-secreting cells admixed with the goblet cells and was devoid of parietal cells); and 5) stratified squamous epithelium; the presence of Paneth cells and serous (pancreatic) cells was seen in CM, OCM, and IM; these cell types did not change the definition of the basic mucosal type and were not considered further in this study. The pathologists evaluating the biopsy samples were blind to all clinical information. The data were recorded and analyzed.
The five epithelial types found were classified as normal and questionably abnormal. The normal epithelia were oxyntic (which lines the entire proximal stomach) and squamous (which lines the esophagus). Questionably abnormal epithelia were OCM, CM, and IM (these will be termed abnormal epithelia in this paper).
Patients were characterized by the biopsy findings into the following groups: Group 1 patients did not have OCM, CM, or IM in two measured biopsy specimens. These include patients whose biopsies had only oxyntic mucosa and squamous epithelium and patients who had OCM, CM, or IM in only one specimen or in the retrograde biopsy and one measured biopsy specimen. These patients either had only oxyntic and squamous epithelia or had OCM, CM, or IM in a length that was <1 cm between oxyntic mucosa and squamous epithelium. Group 2 patients had OCM, CM, or IM in two measured biopsies that were 1 or 2 cm apart. Group 3 patients had OCM, CM, or IM in at least two measured biopsies either 3 or 4 cm apart. Group 4 patients had OCM, CM, and IM in measured biopsies that were Ն5 cm apart.
It should be recognized that this grouping was based only on histologic criteria. To be defined as abnormal columnar epithelium, a specimen had to contain OCM, CM, or IM, irrespective of endoscopic impression. Endoscopic opinion was used in the decision to take biopsies based on a predetermined protocol from locations deemed to be abnormal. Thus, if the biopsy was labeled retrograde, it was classified as normal if it contained 
FIG. 4.
Intestinal metaplastic epithelium characterized by goblet cells. Note that the goblet cells are unevenly distributed in this epithelium and that the only other cell type is a mucous cell. There are no parietal cells. This is therefore equivalent to intestinal metaplasia in cardiac mucosa.
oxyntic mucosa or squamous epithelium and abnormal if it contained OCM, CM, or IM. The utilization of histologic criteria based on definitions that are reproducible makes this classification easy to use and highly reproducible.
RESULTS
Of the 959 patients, 811 (84.6%) fell into group 1 where the length of abnormal columnar epithelium measured 0 to 0.9 cm. Only oxyntic mucosa and squamous epithelium was found in 161 (19.9%) of these patients. These patients had no OCM, CM, or IM and therefore had no histologically defined abnormal columnar epithelium. A total of 158 (19.5%) of the patients had OCM without CM or IM; 372 (45.9%) had CM without IM and 120 (14.8%) of patients had IM (Table 1 and Fig. 5) .
Of the 811 patients in group 1, 17 had biopsies at two measured levels from an endoscopically perceived abnormal columnar epithelium. In these cases, one of the levels contained only oxyntic mucosa and was classified as histologically normal. These are patients in whom the endoscopic impression of an abnormal mucosa was overridden by the histologic finding of normal mucosa. The very small number of such patients attests to a high level of accuracy in endoscopic recognition of abnormal columnar epithelium.
The other 148 patients (15.4%) had two or more measured biopsy levels that contained OCM, CM, or IM. In our biopsy protocol, this is a length of abnormal columnar epithelium that measures a minimum of 1 cm because 1 cm is the smallest interval between measured biopsies. This population was classified into groups 2 to 4 based on increasing lengths of abnormal columnar epithelium that was present in the measured biopsies.
There were 54 patients in group 2 who had abnormal columnar epithelium in measured biopsies that were 1 cm (13 patients) or 2 cm (41 patients). One patient (3.7%) in this group had only OCM; 15 patients (27.8%) had CM without IM, and 38 patients (70.4%) had IM. The greater number of patients with a 2-cm length than a 1-cm length reflects only that a 2-cm biopsy interval was more common than a 1-cm interval in this study, making it necessary to combine patients with 1-cm and 2-cm lengths into one group. Finer groupings than we have presented are possible with a protocol that adheres strictly to 1-cm intervals of measured biopsies, but this is not likely to be practical because of time constraints associated with increasing biopsy numbers. There were 38 patients in group 3 who had abnormal columnar epithelium in measured biopsies that were 3 cm (9 patients) and 4 cm (29 patients). There were no patients without either CM or IM. Four (10.5%) patients had CM without IM and 34 (89.5%) had IM. The greater number of patients with a 4-cm length than a 3-cm length reflects only that a 2-cm biopsy interval was more common than a 1-cm interval in this study.
Group 4 (OCM, CM, or IM present in measured biopsy Ն5 cm apart) had 56 patients. All (100%) of these patients had IM, commonly associated with OCM and CM.
Based on the type of epithelium that was found, we further classified each group into four subgroups: a) patients with only oxyntic mucosa and squamous epithelium and lacking in OCM, CM, or IM; b) patients who had OCM in addition to oxyntic and squamous mucosa; c) patients with CM without IM; and d) patients with IM (Table 1 
DISCUSSION
This is a large series of 959 consecutive patients spanning 3 years who had upper endoscopy and were systematically biopsied according to a defined protocol. The referral nature of the University of Southern California Foregut Surgery Department makes this population biased toward patients with a high prevalence of severe gastroesophageal reflux disease. The endoscopic features observed were used to direct the taking of biopsies at defined levels according to protocol but were not used for any conclusion regarding anatomic location or whether the mucosa was normal or abnormal. Normalcy was defined purely by histologic criteria as follows: 1) gastric oxyntic mucosa and esophageal squamous epithelium were regarded as normal epithelia; 2) the proximal limit of oxyntic mucosa was the histologic gastroesophageal junction; and 3) OCM, CM, and IM were recognized as questionably abnormal epithelia.
The question regarding normalcy of OCM, CM, and IM is controversial. These three epithelial types have been accepted as abnormal epithelia when they occur in the esophagus since the Paull et al. definition of columnar lined esophagus in 1976. 19 Many authorities consider OCM and CM to be also present as native or normal epithelia lining the proximal stomach.
12, 16 We have suggested that this is not correct and that these epithelia are always abnormal when found in this region. [2] [3] [4] There is agreement, even among authorities who suggest that OCM and CM are normally found, that they are found only in millimetric amounts. 12, 16 Our group has provided evidence in a series of prior studies that these epithelia are abnormal, arising from glandular transformation of squamous epithelium as a result of reflux-induced damage.
2-4 Oberg et al. showed that the finding of OCM and CM in endoscopically normal patients correlates with reflux. 18 In this study, 246 of 334 patients who had OCM or CM in a junctional biopsy had a significantly higher level of acid reflux as shown by a 24-hour pH study than 88 of 334 without OCM or CM. 18 Patients with OCM or CM also had lower esophageal sphincter abnormalities more frequently than those without OCM or CM. 18 A similar finding was reported by Clark et al. 7 Chandrasoma et al. reported that the severity of reflux correlated with the length of CM, 3 a finding that was confirmed by Glickman et al. 12 In the Chandrasoma et al. study, patients who had OCM + CM + IM lengths >2 cm had much higher levels of acid reflux as assessed by a 24-hour pH study than patients with <2-cm lengths of these mucosal type. It should be recognized that 24-hour pH study is the most accurate method of assessing reflux and correlations with this standard are much more accurate than using highly subjective symptoms to define severity of clinical reflux. Der et al. showed that CM, when present, is always histologically abnormal with inflammation whose severity correlates with gastroesophageal acid reflux. 9 We have suggested the term "reflux carditis" based on the Der at el. data 9 as a diagnosis when inflamed CM is found in biopsies of this region. In all these studies, CM was defined by histologic criteria. There is no study in which histologically defined CM has had either no correlation or a negative correlation with reflux.
We suggest that the system of purely histologic classification suggested here is more accurate and reproducible than presently used systems that use a combination of endoscopic features and histology. This classification system is suggested as a method of standardizing reporting of biopsies in this region and permitting comparably defined future studies. The final decision as to whether OCM and CM in this region are normal or abnormal must be based on studies that accurately define the prevalence of these histologic mucosal types and determine their clinical significance. Although our studies indicate a clear association between the presence of OCM and CM and reflux, corroboration by other investigators is necessary for this to be accepted.
At present, Barrett esophagus is diagnosed when IM is present in a biopsy taken from an endoscopically visualized abnormal columnar epithelium in the esophagus. 20 This is divided into long segment and short segment based on whether the endoscopically visualized segment is >2 cm or <2 cm. All 56 patients in this study that were in group 4 had IM and fall within the definition of longsegment Barrett esophagus.
Patients in group 3 of this study had an abnormal columnar epithelial length of 3 cm or 4 cm. Of the 38 patients, 34 (89.5%) had IM and would be classified as having long segment Barrett esophagus.
In group 3 were 4 patients (10.5%) who did not have IM despite a 3-to 4-cm length of abnormal columnar epithelium. In the days before IM became a sine qua non for the diagnosis of Barrett esophagus, this group of patients would have been classified as Barrett esophagus of junctional type because all had junctional (cardiac) mucosa. 19 At present, the significance of this finding is considered to be of unknown significance, and termed "columnar lined esophagus without IM." 22 We interpret the presence of an OCM + CM length of Ն3 cm without IM to indicate severe reflux disease because there is a direct correlation between OCM + CM length and acid exposure by 24-hour pH studies. 3, 8 Based on these data, we classify these patients as having severe reflux carditis. This is a rare group of patients because the prevalence of IM reaches 90% at a abnormal columnar epithelial length of 3 cm and 100% at 5 cm.
Group 2 consists of 54 patients who had abnormal columnar epithelium of 1 to 2 cm by measured biopsies. The 38 patients (70.4%) who had IM will fall under the presently accepted definition of short-segment Barrett esophagus. The 15 patients (27.8%) with CM and without IM represent patients who are presently unclassified. These patients are those who are endoscopically suspected of having short-segment Barrett esophagus but do not satisfy the histologic definition of Barrett esophagus. Many authorities will consider this a normal finding despite the overwhelming and undisputed evidence from normal autopsies that nearly all patients without reflux will have a length of CM that is <1 cm. 2, 16 We use the data correlating increasing OCM + CM length with reflux to designate these patients as having moderate reflux carditis. There was one patient in this group who had neither CM nor IM with OCM being the only abnormal epithelium. This is an extremely rare finding; when the abnormal columnar epithelial length exceeds 1 cm, CM and/or IM is almost invariably found.
Group 1 represents the most controversial group; group 1 is also the largest group. Even in this study, which is biased toward patients who have reflux disease, 811 of 959 patients (84.6%) fell into group 1. This contrasts with our study of normal patients at autopsy where 87 of 90 patients (96.7%) had OCM + CM length <1 cm. 2 In the Kilgore et al. autopsy study of children, the maximum CM length was 0.4 cm, placing all their patients (100%) in group 1. 16 This indicates that the 84.6% figure for group 1 in this present study population is reflective of a high prevalence of patients with reflux disease. In centers where patients who are endoscopically normal are not subject to biopsy, the percentage of patients in group 1 has potential to be even lower.
Group 1 includes patients who were endoscopically normal and those in whom any visualized abnormality was so short that it precluded the taking of two measured biopsies 1 cm apart that contained OCM, CM, or IM. In many centers, many of these patients will not undergo biopsies because the practice guidelines for gastroenterologists discourage biopsy when there is no endoscopic abnormality. 20 In studies in which biopsies have been taken from endoscopically normal patients, the results show a great variation in the type of mucosae that are found. 15, 18 In the present series, group 1 contains both patients with normal endoscopic features as well as patients with a very short (<1 cm) segment of abnormal columnar epithelium. We think this grouping is practical because even highly experienced gastroenterologists may not be able to recognize short segments of columnar lining in the lower esophagus. 21 Spechler et al. clearly state that the distinction between the several types of columnar epithelium and gastric epithelium cannot be made by endoscopy and requires histologic examination. 21 Group 1, as we have defined it, represents this group of patients with either normal or minimally and questionably abnormal endoscopic features in whom histology is essential to classify the columnar epithelial types.
A total of 161 (19.9%) patients had no abnormal columnar epithelium in biopsies. This represents patients who do not show any histologic evidence of glandular transformation of squamous epithelium; this is our definition of normal. It is irrelevant whether the endoscopic appearance was normal or not; the absence of OCM, CM, and IM in biopsies defines normalcy.
A total of 158 (19.4%) patients had OCM in their biopsies in addition to oxyntic mucosa and squamous epithelium. We consider the presence of OCM an abnormality associated with reflux because its presence correlates with an abnormal 24-hour pH test. 18 However, we regard this as a relatively benign change because of the almost invariable absence of IM in the parietal cell containing OCM. Paull et al. originally reported the absence of goblet cells in areas of epithelium that contained parietal cells, and our experience has confirmed this finding. 3, 19 Because IM is accepted as the precursor to adenocarcinoma, we classify patients who have only OCM in biopsies as "compensated reflux" because they are not at risk for developing IM and adenocarcinoma.
A total of 372 (45.9%) of patients in this group had CM, often with OCM but without IM. Most centers will ignore this finding at the present time because of the belief that CM is a normal mucosa at the junction. Oberg et al. reported that the finding of CM in a biopsy of the junction, even in patients who are endoscopically normal, correlates with an abnormal 24-hour pH study. 18 Further, Der et al. showed that CM is always abnormal when found and the amount of inflammation correlates with the severity of acid exposure. 9 Glickman et al. recently confirmed the correlation between eosinophil in-filtration of CM and reflux and also showed that patients with CM >0.1 cm had a greater likelihood of reflux than patients with CM <0.1 cm. 12 Based on these data, we classify patients in this group who have CM in their biopsy as "mild reflux carditis."
There were 120 (14.8%) patients in group 1 who had IM. All these patients had goblet cells in CM in varying number. The presence of a single well-defined goblet cell in CM satisfies the definition of IM. We classify patients in group 1 who have IM in CM as ultra-short-segment Barrett esophagus.
The diagnosis of these patients by other authorities depends on factors other than histology. If IM is found within an endoscopically visualized abnormal columnar epithelium, the patient is diagnosed as having shortsegment Barrett esophagus. If IM is found in a biopsy without an endoscopic abnormality, controversy exists whether this represents "ultra-short-segment Barrett esophagus" or "intestinal metaplasia of the gastric cardia." The lack of precision in differentiating normalcy at endoscopy from patients with very short lengths of abnormal columnar mucosa makes these diagnostic distinctions meaningless. 21 In their recent paper, Glickman et al. showed that patients with >1 mm of CM were more likely to have reflux than patients with <1 mm. 12 While endoscopy is highly accurate, it is not likely that it can detect such millimetric lengths of abnormal CM. This results in potential errors in interpretation. We have suggested that these millimetric changes in epithelia are first seen as a microscopic abnormality before they become visible at endoscopy and that histologic criteria should be used to define diseases in this region independent of endoscopic definitions.
In a study of biopsies at the squamocolumnar junction, Spechler et al. reported finding IM in 26 (18%) of 142 patients without endoscopically apparent Barrett esophagus. 21 Of these, 9 (6%) had what would be termed normal endoscopy according to present criteria. The other 17 (12%) patients had columnar epithelium extending up to 3 cm into the distal esophagus; by today's criteria, these patients would be classified as short-segment Barrett esophagus and would fit into groups 1, 2, and 3 by our criteria. Because the prevalence of IM rises so sharply beyond a length of 1 cm, the Spechler et al. 18% prevalence of IM is not dissimilar to the 14.8% prevalence of IM in our study for patients in group 1.
"Intestinal metaplasia of the gastric cardia" is thought to be caused by both reflux and Helicobacter pylori infection. 6, 13 In studies of carditis, confusion results from the variation in the criteria used to define carditis. Goldblum et al. defined carditis as inflammation in a biopsy taken 0.5 cm distal to the gastroesophageal junction Chen et al. defined carditis as the presence of inflammation in a mucosa containing mixed mucus and oxyntic cells in a biopsy taken immediately distal to the squamous epithelium. 6 We define carditis as the presence of inflammation in histologically defined CM without consideration of endoscopic features. 9 These studies cannot be compared in light of the fact that CM is sometimes absent and, when present, is found in the 1-to 5-mm range in the majority of people.
We have found that there are two distinct entities in this region with IM: 1) chronic atrophic gastritis, affecting gastric oxyntic mucosa and associated with Helicobacter pylori or autoimmune gastritis. This involves large areas of the stomach, and the cytokeratin 7/20 pattern is that of gastric IM 11 ; and 2) CM with IM, which is reflux-induced Barrett esophagus. This is restricted to the gastroesophageal junctional region, and the IM has a Barrett pattern of staining with cytokeratin 7/20. When IM is classified according to the histologic type of mucosa in which it is found, the two entities separate out. When IM is classified as being present in a biopsy defined by endoscopic location, admixture of the two entities occurs. In rare cases with concomitant chronic atrophic gastritis with IM and reflux carditis with IM, difficulty may arise in interpreting IM at the junction. But most cases with Barrett-type metaplasia (ie, IM in CM) are easily recognized because the immediately adjacent oxyntic mucosa and distal stomach are normal or do not show atrophic gastritis. 17 The presently used Los Angeles classification for reflux disease is based on endoscopic changes in the squamous epithelium. This is very useful for managing patients with a view to symptomatic relief and healing erosive esophagitis. It does not, however, address the major life-threatening complication of reflux disease (ie, adenocarcinoma). Reflux disease does not cause squamous carcinoma, and the squamous epithelium is irrelevant from an oncologic standpoint. The grading system suggested in the present study focuses on the glandular epithelium. We have suggested previously that the refluxadenocarcinoma sequence passes through cardiac metaplasia of the squamous epithelium, IM, and increasing dysplasia. 4 This grading system permits stratification of patients within this sequence ( Table 1 ). The stratification into groups recognizes the increasing severity of reflux with increasing length of abnormal columnar epithelium in the esophagus. The subgroups within each group recognize the risk of adenocarcinoma that exists with different columnar epithelial types. This grading enables a histologic definition of reflux severity and risk of adenocarcinoma. 
